# A Study of the Effect of RG1662 on Metformin in Healthy Volunteers

> **NCT02342925** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 17 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **OTHER:** Omnipaque 300
- **DRUG:** RG1662
- **DRUG:** metformin

## Key facts

- **NCT ID:** NCT02342925
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02342925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02342925, "A Study of the Effect of RG1662 on Metformin in Healthy Volunteers". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02342925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*